查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球转染技术市场：按产品、方法和应用分类 - 预测（~2028 年）
市场调查报告书
商品编码
1426164

全球转染技术市场：按产品、方法和应用分类 - 预测（~2028 年）

Transfection Technologies Market by Product, Method (Physical, Biochemical, Viral), Application - Global Forecast to 2028
出版日期: | 出版商: MarketsandMarkets | 英文 379 Pages | 订单完成后即时交付

价格
简介目录

全球转染技术市场规模预计将从 2023 年的 12 亿美元增加到 2028 年的 18 亿美元，预测期内复合年增长率为 9.4%。

市场的成长归因于物理转染方法的技术进步、细胞生物学研发力度的加强、对个人化医疗的日益关注以及对先进治疗产品的需求不断增加。

调查范围
调查年份 2021-2028
基准年 2022年
预测期 2023-2028
考虑单位 金额（十亿美元）
部分 按产品、方法、应用程式和最终用户
目标区域 北美、欧洲、亚太地区、拉丁美洲、中东/非洲

2022年，在全球转染技术市场中，以产品类型划分，套件和试剂细分市场占最大份额。对核酸转染细胞的高品质试剂的需求不断增加等因素；对开发个人化药物的日益关注也推动了该市场的成长。此外，随着对先进治疗的需求不断增长，套件和试剂的市场份额预计也会增长。

2022 年，北美主导全球转染技术市场。这一优势归功于通常与药物研发发现和开发相关的学术研究中心的存在。此外，该地区对生技药品和先进剂型的投资也在增加。人们日益需要加快通常需要 10-12 年的药物开发过程，这进一步推动了对转染技术的需求。因此，由于新药的开发以及该地区细胞生物学研究和开发的活性化，北美市场正在成长。

该报告研究了全球转染技术市场，包括按产品、方法、应用、最终用户、地区和参与市场的公司概况分類的趋势。

目录

第一章简介

第二章调查方法

第三章执行摘要

第 4 章重要考察

第五章市场概况

  • 介绍
  • 市场动态
  • 波特五力分析
  • 生态系/市场地图
  • 供应链分析
  • 价值链分析
  • 监管状况
  • 价格分析
  • 技术分析
  • 专利分析
  • 2024-2025年重大会议和活动
  • 影响客户业务的趋势/干扰
  • 主要相关人员和采购标准

第六章转染技术市场，依产品

  • 介绍
  • 套件/试剂
  • 装置

第七章转染技术市场（依方法）

  • 介绍
  • 身体的
  • 基于生物化学
  • 基于病毒载体

第八章转染技术市场（依应用）

  • 介绍
  • 治疗药物的施用
  • 生物医学研究
  • 蛋白质生产
  • 细胞微阵列

第 9 章转染技术市场（依最终用户）

  • 介绍
  • 製药和生物技术公司
  • 合约研究组织、合约研发生产组织
  • 学术研究所
  • 其他的

第10章转染技术市场，依地区

  • 介绍
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲

第十一章竞争形势

  • 概述
  • 主要参与企业的策略/秘密
  • 收益占有率分析
  • 市场占有率分析
  • 企业评价矩阵：主要企业
  • 公司评估矩阵：Start-Ups/中小企业
  • 竞争场景

第十二章 公司简介

  • 主要参与企业
    • THERMO FISHER SCIENTIFIC INC.
    • BIO-RAD LABORATORIES, INC.
    • QIAGEN
    • MERCK KGAA
    • SARTORIUS AG（POLYPLUS）
    • LONZA
    • F. HOFFMANN-LA ROCHE LTD.
    • AGILENT TECHNOLOGIES, INC.
    • MAXCYTE
    • REVVITY
    • TAKARA BIO INC.
    • PROMEGA CORPORATION
    • DANAHER CORPORATION
  • 其他公司
    • BOC SCIENCES
    • RJH BIOSCIENCES
    • SYNVOLUX
    • ALTOGEN BIOSYSTEMS
    • BIOIVT
    • INCELLA GMBH
    • INVIVOGEN
    • PHOREUS BIOTECH
    • STEMCELL TECHNOLOGIES
    • EZ BIOSYSTEMS
    • OZ BIOSCIENCES
    • CHEMICELL GMBH

第十三章附录

简介目录
Product Code: BT 1355

The transfection technologies market is projected to reach USD 1.8 billion by 2028 from an estimated USD 1.2 billion in 2023, at a CAGR of 9.4% during the forecast period. The growth of this market can be attributed to the technological advancements in physical transfection methods, increasing research and development efforts in cell biology, growing focus on personalized medicines, and rising demand for advanced therapeutic products.

Scope of the Report
Years Considered for the Study2021-2028
Base Year2022
Forecast Period2023-2028
Units ConsideredValue (USD) Billion
SegmentsProduct Type, Method, Application, and End User
Regions coveredNorth America, Europe, Asia Pacific, Latin America, and the Middle East and Africa

"The kits & reagents segment accounted for the largest share by product type in 2022."

In 2022, the kits & reagents segment accounted for the largest share of product type in the global transfection technologies market. The factors like growing demand for high quality reagents to transfect nucleic acids into cells. The increasing focus on development of personalized medicines is also driving the growth of this market. Furthermore, the market share of the kits & reagents market is expected to grow simultaneously with the increasing need for advanced therapies.

"The North America dominated the transfection technologies market during the forecast period of 2023-2028."

North America dominated the global transfection technologies market in 2022. This dominance is attributed to the presence of academic and research centers, often associated with drug discovery and development. Additionally, the region is experiencing increased investments in biologics and advanced dosage forms. The growing need to expedite the drug development process, which typically spans 10 to 12 years, has further fueled the demand for transfection technologies. Consequently, the North America market is witnessing growth due to the development of novel drug products and the growing research and development in cell biology efforts in the region.

The primary interviews conducted for this report can be categorized as follows:

  • By Respondent: Supply Side- 70% and Demand Side 30%
  • By Designation: Managers - 45%, CXO & Directors - 30%, and Executives - 25%
  • By Region: North America -35%, Europe -20%, Asia-Pacific -25%, Latin America -15% and Middle East & Africa- 5%

List of Companies Profiled in the Report:

  • Thermo Fisher Scientific Inc. (US)
  • Bio-Rad Laboratories, Inc. (US)
  • QIAGEN (Netherlands)
  • Merck KGaA (Germany)
  • Sartorius AG (Polyplus) (Germany)
  • Lonza (Switzerland)
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • Agilent Technologies, Inc. (US)
  • MaxCyte (US)
  • Revvity (US)
  • Takara Bio Inc. (Japan)
  • Promega Corporation (US)
  • Danaher Corporation (US)
  • BOC Sciences (US)
  • RJH BIOSCIENCES (Canada)
  • Synvolux (Netherlands)
  • Altogen Biosciences (US)
  • BioIVT (US)
  • Incella GmbH (Germany)
  • InvivoGen (France)
  • Phoreus Biotech (US)
  • STEMCELL Technologies (Canada)
  • EZ Biosystems (US)
  • OZ Biosciences (France)
  • chemicell GmbH (Germany)

Research Coverage:

This research report categorizes the transfection technologies market by product type (kits & reagents and equipment), method (physical transfection (electroporation, bistolic technology, microinjection, and other physical transfection methods), biochemical transfection (lipofection, calcium phosphate, cationic polymer, dendrimer mediated transfection, and DEAE dextran), viral vector transfection), application (biomedical research, therapeutic delivery, protein production, and cell based microarray), end user (pharmaceutical and biotechnology companies, Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO), academic and research institutes, and other end users)

The report's scope encompasses detailed information regarding major influencing factors such as drivers, trends, challenges, and opportunities shaping the growth of the transfection technologies market. A comprehensive analysis of key industry players has been conducted to offer insights into their business overview, products, key strategies, collaborations, partnerships, and agreements. The report also covers recent developments, including new product launches, mergers, and acquisitions, in the transfection technologies market.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall transfection technologies market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

  • Analysis of key drivers (Increasing demand for cell and gene therapy, rising research activities and R&D funding, technological advancements), restraints (limited efficiency of transfection methods, adoption of alternative methods), opportunities (rising focus on personalized medicine, growth opportunities in emerging economies), and challenges (concerns related to cytotoxicity and transfection in hard-to-transfect cells, challenges associated with large scale transfection processes) influencing the growth of the market.
  • Product Development/Innovation: Detailed insights on newly launched products of the transfection technologies market
  • Market Development: Comprehensive information about lucrative markets - the report analyses the market across varied regions.
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the transfection technologies market
  • Competitive Assessment: Thermo Fisher Scientific Inc. (US), Bio-Rad Laboratories, Inc. (US), QIAGEN (Netherlands), Merck KGaA (Germany), Sartorius AG (Polyplus) (Germany), Lonza (Switzerland), F. Hoffmann-La Roche Ltd (Switzerland), Agilent Technologies, Inc. (US), MaxCyte (US), Revvity (US), Takara Bio Inc. (Japan), Promega Corporation (US), Danaher Corporation (US), BOC Sciences (US), RJH BIOSCIENCES (Canada), Synvolux (Netherlands), Altogen Biosciences (US), BioIVT (US), Incella GmbH (Germany), InvivoGen (France), Phoreus Biotech (US), STEMCELL Technologies (Canada), EZ Biosystems (US), OZ Biosciences (France), chemicell GmbH (Germany), and among others in the market.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS AND EXCLUSIONS
  • 1.3 STUDY SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 YEARS CONSIDERED
    • 1.3.3 CURRENCY CONSIDERED
  • 1.4 STAKEHOLDERS
  • 1.5 SUMMARY OF CHANGES
  • 1.6 RECESSION IMPACT

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 1 RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
    • 2.1.2 PRIMARY DATA
    • FIGURE 2 TRANSFECTION TECHNOLOGIES MARKET: BREAKDOWN OF PRIMARIES
  • 2.2 MARKET SIZE ESTIMATION
    • 2.2.1 BOTTOM-UP APPROACH
    • FIGURE 3 TRANSFECTION TECHNOLOGIES MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2022
    • FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (REVENUE SHARE ANALYSIS), 2022
    • FIGURE 5 ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE ANALYSIS, 2022
      • 2.2.1.1 Insights from primaries
    • FIGURE 6 MARKET VALIDATION FROM PRIMARY EXPERTS
    • 2.2.2 TOP-DOWN APPROACH
    • FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • 2.3 GROWTH RATE ASSUMPTIONS/GROWTH FORECAST
    • FIGURE 8 TRANSFECTION TECHNOLOGIES MARKET: CAGR PROJECTIONS
    • FIGURE 9 TRANSFECTION TECHNOLOGIES MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • 2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
    • FIGURE 10 DATA TRIANGULATION METHODOLOGY
  • 2.5 RESEARCH ASSUMPTIONS
  • 2.6 LIMITATIONS
  • 2.7 RISK ANALYSIS
  • 2.8 RECESSION IMPACT ANALYSIS

3 EXECUTIVE SUMMARY

    • FIGURE 11 TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION)
    • FIGURE 12 TRANSFECTION TECHNOLOGIES MARKET, BY METHOD, 2023 VS. 2028 (USD MILLION)
    • FIGURE 13 TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
    • FIGURE 14 TRANSFECTION TECHNOLOGIES MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
    • FIGURE 15 TRANSFECTION TECHNOLOGIES MARKET: GEOGRAPHIC ANALYSIS

4 PREMIUM INSIGHTS

  • 4.1 TRANSFECTION TECHNOLOGIES MARKET OVERVIEW
    • FIGURE 16 GROWING DEMAND FOR CELL AND GENE THERAPY TO DRIVE MARKET GROWTH
  • 4.2 ASIA PACIFIC: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT AND COUNTRY
    • FIGURE 17 KITS & REAGENTS HELD LARGEST SHARE OF ASIA PACIFIC MARKET IN 2022
  • 4.3 TRANSFECTION TECHNOLOGIES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • FIGURE 18 INDIA TO REGISTER HIGHEST CAGR IN GLOBAL TRANSFECTION TECHNOLOGIES MARKET OVER FORECAST PERIOD
  • 4.4 TRANSFECTION TECHNOLOGIES MARKET SHARE, BY PRODUCT, 2022
    • FIGURE 19 KITS & REAGENTS HELD LARGEST SHARE OF PRODUCTS MARKET IN 2022

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 20 TRANSFECTION TECHNOLOGIES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • TABLE 1 TRANSFECTION TECHNOLOGIES MARKET: IMPACT ANALYSIS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Increasing demand for cell and gene therapy
    • FIGURE 21 ESTIMATED CANCER CASELOAD, BY REGION
    • FIGURE 22 COMPARATIVE DATA FOR TOTAL NUMBER OF CLINICAL TRIALS
      • 5.2.1.2 Rising research activity and R&D funding
      • 5.2.1.3 Alliances for developing advanced therapeutic products
      • 5.2.1.4 Expanded applications of transfection technologies
      • 5.2.1.5 Technological advancements
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Limited efficiency of transfection methods
      • 5.2.2.2 High cost of transfection products
      • 5.2.2.3 Adoption of alternative methods
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Rising focus on personalized medicines
      • 5.2.3.2 Growth opportunities in emerging economies
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Concern related to cytotoxicity and transfection in hard-to-transfect cells
      • 5.2.4.2 Challenges associated with large-scale transfection processes
  • 5.3 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 2 TRANSFECTION TECHNOLOGIES MARKET: PORTER'S FIVE FORCES ANALYSIS
    • 5.3.1 THREAT OF NEW ENTRANTS
    • 5.3.2 THREAT OF SUBSTITUTES
    • 5.3.3 BARGAINING POWER OF SUPPLIERS
    • 5.3.4 BARGAINING POWER OF BUYERS
    • 5.3.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.4 ECOSYSTEM/MARKET MAP
    • FIGURE 23 TRANSFECTION TECHNOLOGIES MARKET: ECOSYSTEM
    • 5.4.1 PRODUCT VENDORS
    • TABLE 3 TRANSFECTION TECHNOLOGIES MARKET: PRODUCT VENDORS
    • 5.4.2 END USERS
    • TABLE 4 TRANSFECTION TECHNOLOGIES MARKET: END USERS
    • 5.4.3 REGULATORY BODIES
    • TABLE 5 TRANSFECTION TECHNOLOGIES MARKET: REGULATORY BODIES
  • 5.5 SUPPLY CHAIN ANALYSIS
    • FIGURE 24 TRANSFECTION TECHNOLOGIES MARKET: SUPPLY CHAIN ANALYSIS
  • 5.6 VALUE CHAIN ANALYSIS
    • FIGURE 25 VALUE CHAIN ANALYSIS OF TRANSFECTION TECHNOLOGIES MARKET: R&D AND MANUFACTURING PHASES ADD MAXIMUM VALUE
  • 5.7 REGULATORY LANDSCAPE
    • 5.7.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 6 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 7 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 8 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 9 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.8 PRICING ANALYSIS
    • TABLE 10 AVERAGE SELLING PRICE, BY COMPANY, 2022
    • TABLE 11 AVERAGE SELLING PRICE, BY REGION
  • 5.9 TECHNOLOGY ANALYSIS
    • TABLE 12 TRANSFECTION TECHNOLOGIES MARKET: PROMINENT TECHNOLOGIES AND THEIR IMPACTS
  • 5.10 PATENT ANALYSIS
    • FIGURE 26 PATENT APPLICATIONS FOR TRANSFECTION TECHNOLOGIES MARKET, JANUARY 2013-OCTOBER 2023
    • TABLE 13 TRANSFECTION TECHNOLOGIES MARKET: INDICATIVE LIST OF PATENTS
  • 5.11 KEY CONFERENCES AND EVENTS, 2024-2025
    • TABLE 14 TRANSFECTION TECHNOLOGIES MARKET: DETAILED LIST OF CONFERENCES AND EVENTS, 2024-2025
  • 5.12 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
    • FIGURE 27 REVENUE SHIFT AND NEW POCKETS FOR TRANSFECTION PRODUCT PROVIDERS
  • 5.13 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • FIGURE 28 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF TRANSFECTION PRODUCTS
    • 5.13.2 BUYING CRITERIA FOR TRANSFECTION PRODUCTS
    • FIGURE 29 KEY BUYING CRITERIA FOR END USERS
    • TABLE 15 KEY BUYING CRITERIA FOR END USERS

6 TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT

  • 6.1 INTRODUCTION
    • TABLE 16 TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • 6.2 KITS & REAGENTS
    • 6.2.1 KITS & REAGENTS SEGMENT TO HOLD LARGEST SHARE OF PRODUCTS MARKET
    • TABLE 17 TRANSFECTION KITS & REAGENTS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 18 NORTH AMERICA: TRANSFECTION KITS & REAGENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 19 EUROPE: TRANSFECTION KITS & REAGENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 20 ASIA PACIFIC: TRANSFECTION KITS & REAGENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 21 LATIN AMERICA: TRANSFECTION KITS & REAGENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 22 MIDDLE EAST & AFRICA: TRANSFECTION KITS & REAGENTS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 23 MIDDLE EAST: TRANSFECTION KITS & REAGENTS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 6.3 EQUIPMENT
    • 6.3.1 TECHNOLOGICAL DEVELOPMENTS AND RISING ADOPTION OF INNOVATIVE PRODUCTS TO BOOST MARKET GROWTH
    • TABLE 24 TRANSFECTION EQUIPMENT MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 25 NORTH AMERICA: TRANSFECTION EQUIPMENT MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 26 EUROPE: TRANSFECTION EQUIPMENT MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 27 ASIA PACIFIC: TRANSFECTION EQUIPMENT MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 28 LATIN AMERICA: TRANSFECTION EQUIPMENT MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 29 MIDDLE EAST & AFRICA: TRANSFECTION EQUIPMENT MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 30 MIDDLE EAST: TRANSFECTION EQUIPMENT MARKET, BY REGION, 2021-2028 (USD MILLION)

7 TRANSFECTION TECHNOLOGIES MARKET, BY METHOD

  • 7.1 INTRODUCTION
    • TABLE 31 TRANSFECTION TECHNOLOGIES MARKET, BY METHOD, 2021-2028 (USD MILLION)
  • 7.2 PHYSICAL TRANSFECTION
    • TABLE 32 PHYSICAL TRANSFECTION MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 33 NORTH AMERICA: PHYSICAL TRANSFECTION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 34 EUROPE: PHYSICAL TRANSFECTION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 35 ASIA PACIFIC: PHYSICAL TRANSFECTION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 36 LATIN AMERICA: PHYSICAL TRANSFECTION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 37 MIDDLE EAST & AFRICA: PHYSICAL TRANSFECTION MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 38 MIDDLE EAST: PHYSICAL TRANSFECTION MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 39 PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • 7.2.1 ELECTROPORATION
      • 7.2.1.1 Growing demand for efficient cell transfection technologies to drive growth
    • TABLE 40 ELECTROPORATION MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 41 NORTH AMERICA: ELECTROPORATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 42 EUROPE: ELECTROPORATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 43 ASIA PACIFIC: ELECTROPORATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 44 LATIN AMERICA: ELECTROPORATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 45 MIDDLE EAST & AFRICA: ELECTROPORATION MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 46 MIDDLE EAST: ELECTROPORATION MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 7.2.2 BIOLISTIC TRANSFECTION/GENE GUNS
      • 7.2.2.1 Increasing focus on rapid and simple techniques to support market growth
    • TABLE 47 BIOLISTIC TRANSFECTION/GENE GUNS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 48 NORTH AMERICA: BIOLISTIC TRANSFECTION/GENE GUNS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 49 EUROPE: BIOLISTIC TRANSFECTION/GENE GUNS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 50 ASIA PACIFIC: BIOLISTIC TRANSFECTION/GENE GUNS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 51 LATIN AMERICA: BIOLISTIC TRANSFECTION/GENE GUNS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 52 MIDDLE EAST & AFRICA: BIOLISTIC TRANSFECTION/GENE GUNS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 53 MIDDLE EAST: BIOLISTIC TRANSFECTION/GENE GUNS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 7.2.3 MICROINJECTION
      • 7.2.3.1 Rising need for advanced cell transfection techniques to drive adoption
    • TABLE 54 MICROINJECTION MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 55 NORTH AMERICA: MICROINJECTION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 56 EUROPE: MICROINJECTION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 57 ASIA PACIFIC: MICROINJECTION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 58 LATIN AMERICA: MICROINJECTION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 59 MIDDLE EAST & AFRICA: MICROINJECTION MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 60 MIDDLE EAST: MICROINJECTION MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 7.2.4 OTHER PHYSICAL TRANSFECTION METHODS
    • TABLE 61 OTHER PHYSICAL TRANSFECTION METHODS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 62 NORTH AMERICA: OTHER PHYSICAL TRANSFECTION METHODS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 63 EUROPE: OTHER PHYSICAL TRANSFECTION METHODS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 64 ASIA PACIFIC: OTHER PHYSICAL TRANSFECTION METHODS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 65 LATIN AMERICA: OTHER PHYSICAL TRANSFECTION METHODS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 66 MIDDLE EAST & AFRICA: OTHER PHYSICAL TRANSFECTION METHODS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 67 MIDDLE EAST: OTHER PHYSICAL TRANSFECTION METHODS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 7.3 BIOCHEMICAL-BASED TRANSFECTION
    • TABLE 68 BIOCHEMICAL-BASED TRANSFECTION MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 69 NORTH AMERICA: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 70 EUROPE: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 71 ASIA PACIFIC: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 72 LATIN AMERICA: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 73 MIDDLE EAST & AFRICA: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 74 MIDDLE EAST: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 75 BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • 7.3.1 LIPOFECTION
      • 7.3.1.1 High efficiency and compatibility to drive adoption
    • TABLE 76 LIPOFECTION MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 77 NORTH AMERICA: LIPOFECTION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 78 EUROPE: LIPOFECTION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 79 ASIA PACIFIC: LIPOFECTION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 80 LATIN AMERICA: LIPOFECTION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 81 MIDDLE EAST & AFRICA: LIPOFECTION MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 82 MIDDLE EAST: LIPOFECTION MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 7.3.2 CALCIUM PHOSPHATE TRANSFECTION
      • 7.3.2.1 Increasing R&D in cell-based therapies to drive market
    • TABLE 83 CALCIUM PHOSPHATE TRANSFECTION MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 84 NORTH AMERICA: CALCIUM PHOSPHATE TRANSFECTION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 85 EUROPE: CALCIUM PHOSPHATE TRANSFECTION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 86 ASIA PACIFIC: CALCIUM PHOSPHATE TRANSFECTION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 87 LATIN AMERICA: CALCIUM PHOSPHATE TRANSFECTION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 88 MIDDLE EAST & AFRICA: CALCIUM PHOSPHATE TRANSFECTION MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 89 MIDDLE EAST: CALCIUM PHOSPHATE TRANSFECTION MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 7.3.3 CATIONIC POLYMER TRANSFECTION
      • 7.3.3.1 Adoption of innovative biochemical materials for transfection to accelerate growth
    • TABLE 90 CATIONIC POLYMER TRANSFECTION MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 91 NORTH AMERICA: CATIONIC POLYMER TRANSFECTION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 92 EUROPE: CATIONIC POLYMER TRANSFECTION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 93 ASIA PACIFIC: CATIONIC POLYMER TRANSFECTION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 94 LATIN AMERICA: CATIONIC POLYMER TRANSFECTION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 95 MIDDLE EAST & AFRICA: CATIONIC POLYMER TRANSFECTION MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 96 MIDDLE EAST: CATIONIC POLYMER TRANSFECTION MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 7.3.4 DEAE-DEXTRAN TRANSFECTION
      • 7.3.4.1 Simplicity, rapidity, and cost-effectiveness to support adoption
    • TABLE 97 DEAE-DEXTRAN TRANSFECTION MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 98 NORTH AMERICA: DEAE-DEXTRAN TRANSFECTION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 99 EUROPE: DEAE-DEXTRAN TRANSFECTION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 100 ASIA PACIFIC: DEAE-DEXTRAN TRANSFECTION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 101 LATIN AMERICA: DEAE-DEXTRAN TRANSFECTION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 102 MIDDLE EAST & AFRICA: DEAE-DEXTRAN TRANSFECTION MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 103 MIDDLE EAST: DEAE-DEXTRAN TRANSFECTION MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 7.3.5 MAGNET-ASSISTED TRANSFECTION
      • 7.3.5.1 Rising emphasis on innovative therapies for genetic disorders to drive adoption
    • TABLE 104 MAGNET-ASSISTED TRANSFECTION MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 105 NORTH AMERICA: MAGNET-ASSISTED TRANSFECTION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 106 EUROPE: MAGNET-ASSISTED TRANSFECTION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 107 ASIA PACIFIC: MAGNET-ASSISTED TRANSFECTION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 108 LATIN AMERICA: MAGNET-ASSISTED TRANSFECTION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 109 MIDDLE EAST & AFRICA: MAGNET-ASSISTED TRANSFECTION MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 110 MIDDLE EAST: MAGNET-ASSISTED TRANSFECTION MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 7.3.6 DENDRIMER-MEDIATED TRANSFECTION
      • 7.3.6.1 Non-biodegradable properties to restrain market growth
    • TABLE 111 DENDRIMER-MEDIATED TRANSFECTION MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 112 NORTH AMERICA: DENDRIMER-MEDIATED TRANSFECTION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 113 EUROPE: DENDRIMER-MEDIATED TRANSFECTION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 114 ASIA PACIFIC: DENDRIMER-MEDIATED TRANSFECTION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 115 LATIN AMERICA: DENDRIMER-MEDIATED TRANSFECTION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 116 MIDDLE EAST & AFRICA: DENDRIMER-MEDIATED TRANSFECTION MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 117 MIDDLE EAST: DENDRIMER-MEDIATED TRANSFECTION MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 7.4 VIRAL-VECTOR BASED TRANSFECTION
    • 7.4.1 TECHNOLOGICAL DEVELOPMENTS AND GROWING NEED FOR CELL & GENE THERAPY TO DRIVE MARKET
    • TABLE 118 VIRAL VECTOR-BASED TRANSFECTION MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 119 NORTH AMERICA: VIRAL VECTOR-BASED TRANSFECTION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 120 EUROPE: VIRAL VECTOR-BASED TRANSFECTION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 121 ASIA PACIFIC: VIRAL VECTOR-BASED TRANSFECTION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 122 LATIN AMERICA: VIRAL VECTOR-BASED TRANSFECTION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 123 MIDDLE EAST & AFRICA: VIRAL VECTOR-BASED TRANSFECTION MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 124 MIDDLE EAST: VIRAL VECTOR-BASED TRANSFECTION MARKET, BY REGION, 2021-2028 (USD MILLION)

8 TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION

  • 8.1 INTRODUCTION
    • TABLE 125 TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • 8.2 THERAPEUTIC DELIVERY
    • TABLE 126 TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 127 NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 128 EUROPE: TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 129 ASIA PACIFIC: TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 130 LATIN AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 131 MIDDLE EAST & AFRICA: TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 132 MIDDLE EAST: TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 133 TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021-2028 (USD MILLION)
    • 8.2.1 BIOTHERAPEUTICS
      • 8.2.1.1 Rising need for cell and gene therapy to promote growth
    • TABLE 134 TRANSFECTION TECHNOLOGIES MARKET FOR BIOTHERAPEUTICS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 135 NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR BIOTHERAPEUTICS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 136 EUROPE: TRANSFECTION TECHNOLOGIES MARKET FOR BIOTHERAPEUTICS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 137 ASIA PACIFIC: TRANSFECTION TECHNOLOGIES MARKET FOR BIOTHERAPEUTICS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 138 LATIN AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR BIOTHERAPEUTICS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 139 MIDDLE EAST & AFRICA: TRANSFECTION TECHNOLOGIES MARKET FOR BIOTHERAPEUTICS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 140 MIDDLE EAST: TRANSFECTION TECHNOLOGIES MARKET FOR BIOTHERAPEUTICS, BY REGION, 2021-2028 (USD MILLION)
    • 8.2.2 ELECTROIMMUNOTHERAPY
      • 8.2.2.1 Increasing rate of chronic and immunological diseases to accelerate market growth
    • TABLE 141 TRANSFECTION TECHNOLOGIES MARKET FOR ELECTROIMMUNOTHERAPY, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 142 NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR ELECTROIMMUNOTHERAPY, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 143 EUROPE: TRANSFECTION TECHNOLOGIES MARKET FOR ELECTROIMMUNOTHERAPY, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 144 ASIA PACIFIC: TRANSFECTION TECHNOLOGIES MARKET FOR ELECTROIMMUNOTHERAPY, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 145 LATIN AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR ELECTROIMMUNOTHERAPY, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 146 MIDDLE EAST & AFRICA: TRANSFECTION TECHNOLOGIES MARKET FOR ELECTROIMMUNOTHERAPY, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 147 MIDDLE EAST: TRANSFECTION TECHNOLOGIES MARKET FOR ELECTROIMMUNOTHERAPY, BY REGION, 2021-2028 (USD MILLION)
    • 8.2.3 ELECTROCHEMOTHERAPY
      • 8.2.3.1 Need for advanced chemotherapy due to rising cancer incidence to drive market
    • TABLE 148 TRANSFECTION TECHNOLOGIES MARKET FOR ELECTROCHEMOTHERAPY, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 149 NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR ELECTROCHEMOTHERAPY, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 150 EUROPE: TRANSFECTION TECHNOLOGIES MARKET FOR ELECTROCHEMOTHERAPY, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 151 ASIA PACIFIC: TRANSFECTION TECHNOLOGIES MARKET FOR ELECTROCHEMOTHERAPY, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 152 LATIN AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR ELECTROCHEMOTHERAPY, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 153 MIDDLE EAST & AFRICA: TRANSFECTION TECHNOLOGIES MARKET FOR ELECTROCHEMOTHERAPY, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 154 MIDDLE EAST: TRANSFECTION TECHNOLOGIES MARKET FOR ELECTROCHEMOTHERAPY, BY REGION, 2021-2028 (USD MILLION)
  • 8.3 BIOMEDICAL RESEARCH
    • TABLE 155 TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 156 NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 157 EUROPE: TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 158 ASIA PACIFIC: TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 159 LATIN AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 160 MIDDLE EAST & AFRICA: TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 161 MIDDLE EAST: TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 162 TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021-2028 (USD MILLION)
    • 8.3.1 GENE & PROTEIN EXPRESSION STUDIES
      • 8.3.1.1 Efforts to develop advanced gene therapy and genomic medicine promote growth
    • TABLE 163 TRANSFECTION TECHNOLOGIES MARKET FOR GENE & PROTEIN EXPRESSION STUDIES, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 164 NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR GENE & PROTEIN EXPRESSION STUDIES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 165 EUROPE: TRANSFECTION TECHNOLOGIES MARKET FOR GENE & PROTEIN EXPRESSION STUDIES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 166 ASIA PACIFIC: TRANSFECTION TECHNOLOGIES MARKET FOR GENE & PROTEIN EXPRESSION STUDIES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 167 LATIN AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR GENE & PROTEIN EXPRESSION STUDIES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 168 MIDDLE EAST & AFRICA: TRANSFECTION TECHNOLOGIES MARKET FOR GENE & PROTEIN EXPRESSION STUDIES, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 169 MIDDLE EAST: TRANSFECTION TECHNOLOGIES MARKET FOR GENE & PROTEIN EXPRESSION STUDIES, BY REGION, 2021-2028 (USD MILLION)
    • 8.3.2 CANCER RESEARCH
      • 8.3.2.1 Increasing prevalence of cancer to propel market growth
    • TABLE 170 TRANSFECTION TECHNOLOGIES MARKET FOR CANCER RESEARCH, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 171 NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR CANCER RESEARCH, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 172 EUROPE: TRANSFECTION TECHNOLOGIES MARKET FOR CANCER RESEARCH, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 173 ASIA PACIFIC: TRANSFECTION TECHNOLOGIES MARKET FOR CANCER RESEARCH, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 174 LATIN AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR CANCER RESEARCH, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 175 MIDDLE EAST & AFRICA: TRANSFECTION TECHNOLOGIES MARKET FOR CANCER RESEARCH, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 176 MIDDLE EAST: TRANSFECTION TECHNOLOGIES MARKET FOR CANCER RESEARCH, BY REGION, 2021-2028 (USD MILLION)
    • 8.3.3 TRANSGENIC MODELS
      • 8.3.3.1 Growing R&D activities and clinical studies to drive market
    • TABLE 177 TRANSFECTION TECHNOLOGIES MARKET FOR TRANSGENIC MODELS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 178 NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR TRANSGENIC MODELS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 179 EUROPE: TRANSFECTION TECHNOLOGIES MARKET FOR TRANSGENIC MODELS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 180 ASIA PACIFIC: TRANSFECTION TECHNOLOGIES MARKET FOR TRANSGENIC MODELS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 181 LATIN AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR TRANSGENIC MODELS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 182 MIDDLE EAST & AFRICA: TRANSFECTION TECHNOLOGIES MARKET FOR TRANSGENIC MODELS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 183 MIDDLE EAST: TRANSFECTION TECHNOLOGIES MARKET FOR TRANSGENIC MODELS, BY REGION, 2021-2028 (USD MILLION)
  • 8.4 PROTEIN PRODUCTION
    • 8.4.1 INCREASING INCIDENCE OF CHRONIC DISEASES AND DEMAND FOR PROTEIN THERAPEUTICS TO PROMOTE GROWTH
    • TABLE 184 TRANSFECTION TECHNOLOGIES MARKET FOR PROTEIN PRODUCTION, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 185 NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR PROTEIN PRODUCTION, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 186 EUROPE: TRANSFECTION TECHNOLOGIES MARKET FOR PROTEIN PRODUCTION, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 187 ASIA PACIFIC: TRANSFECTION TECHNOLOGIES MARKET FOR PROTEIN PRODUCTION, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 188 LATIN AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR PROTEIN PRODUCTION, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 189 MIDDLE EAST & AFRICA: TRANSFECTION TECHNOLOGIES MARKET FOR PROTEIN PRODUCTION, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 190 MIDDLE EAST: TRANSFECTION TECHNOLOGIES MARKET FOR PROTEIN PRODUCTION, BY REGION, 2021-2028 (USD MILLION)
  • 8.5 CELL-BASED MICROARRAYS
    • 8.5.1 INCREASING NEED FOR CELL-BASED THERAPIES TO DRIVE MARKET
    • TABLE 191 TRANSFECTION TECHNOLOGIES MARKET FOR CELL-BASED MICROARRAYS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 192 NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR CELL-BASED MICROARRAYS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 193 EUROPE: TRANSFECTION TECHNOLOGIES MARKET FOR CELL-BASED MICROARRAYS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 194 ASIA PACIFIC: TRANSFECTION TECHNOLOGIES MARKET FOR CELL-BASED MICROARRAYS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 195 LATIN AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR CELL-BASED MICROARRAYS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 196 MIDDLE EAST & AFRICA: TRANSFECTION TECHNOLOGIES MARKET FOR CELL-BASED MICROARRAYS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 197 MIDDLE EAST: TRANSFECTION TECHNOLOGIES MARKET FOR CELL-BASED MICROARRAYS, BY REGION, 2021-2028 (USD MILLION)

9 TRANSFECTION TECHNOLOGIES MARKET, BY END USER

  • 9.1 INTRODUCTION
    • TABLE 198 TRANSFECTION TECHNOLOGIES MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    • 9.2.1 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO DOMINATE END-USER MARKET
    • TABLE 199 TRANSFECTION TECHNOLOGIES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 200 NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 201 EUROPE: TRANSFECTION TECHNOLOGIES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 202 ASIA PACIFIC: TRANSFECTION TECHNOLOGIES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 203 LATIN AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 204 MIDDLE EAST & AFRICA: TRANSFECTION TECHNOLOGIES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 205 MIDDLE EAST: TRANSFECTION TECHNOLOGIES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021-2028 (USD MILLION)
  • 9.3 CROS & CDMOS
    • 9.3.1 CONTRACT RESEARCH AND MANUFACTURING SECTOR TO SEE STRONG GROWTH
    • TABLE 206 TRANSFECTION TECHNOLOGIES MARKET FOR CROS & CDMOS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 207 NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR CROS & CDMOS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 208 EUROPE: TRANSFECTION TECHNOLOGIES MARKET FOR CROS & CDMOS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 209 ASIA PACIFIC: TRANSFECTION TECHNOLOGIES MARKET FOR CROS & CDMOS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 210 LATIN AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR CROS & CDMOS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 211 MIDDLE EAST & AFRICA: TRANSFECTION TECHNOLOGIES MARKET FOR CROS & CDMOS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 212 MIDDLE EAST: TRANSFECTION TECHNOLOGIES MARKET FOR CROS & CDMOS, BY REGION, 2021-2028 (USD MILLION)
  • 9.4 ACADEMIC & RESEARCH INSTITUTES
    • 9.4.1 INCREASING R&D AND GROWING TREND OF COLLABORATIVE RESEARCH TO PROMOTE MARKET GROWTH
    • TABLE 213 TRANSFECTION TECHNOLOGIES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 214 NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 215 EUROPE: TRANSFECTION TECHNOLOGIES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 216 ASIA PACIFIC: TRANSFECTION TECHNOLOGIES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 217 LATIN AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 218 MIDDLE EAST & AFRICA: TRANSFECTION TECHNOLOGIES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 219 MIDDLE EAST: TRANSFECTION TECHNOLOGIES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2021-2028 (USD MILLION)
  • 9.5 OTHER END USERS
    • TABLE 220 TRANSFECTION TECHNOLOGIES MARKET FOR OTHER END USERS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 221 NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 222 EUROPE: TRANSFECTION TECHNOLOGIES MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 223 ASIA PACIFIC: TRANSFECTION TECHNOLOGIES MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 224 LATIN AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 225 MIDDLE EAST & AFRICA: TRANSFECTION TECHNOLOGIES MARKET FOR OTHER END USERS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 226 MIDDLE EAST: TRANSFECTION TECHNOLOGIES MARKET FOR OTHER END USERS, BY REGION, 2021-2028 (USD MILLION)

10 TRANSFECTION TECHNOLOGIES MARKET, BY REGION

  • 10.1 INTRODUCTION
    • TABLE 227 TRANSFECTION TECHNOLOGIES MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 10.2 NORTH AMERICA
    • 10.2.1 NORTH AMERICA: RECESSION IMPACT
    • FIGURE 30 NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET SNAPSHOT
    • TABLE 228 NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 229 NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 230 NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET, BY METHOD, 2021-2028 (USD MILLION)
    • TABLE 231 NORTH AMERICA: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 232 NORTH AMERICA: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 233 NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 234 NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 235 NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 236 NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.2.2 US
      • 10.2.2.1 US to dominate North American market
    • TABLE 237 US: INDICATIVE LIST OF THERAPIES APPROVED IN 2022
    • TABLE 238 US: INDICATIVE LIST OF PRODUCTS ANTICIPATED TO BE APPROVED IN 2023
    • TABLE 239 US: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 240 US: TRANSFECTION TECHNOLOGIES MARKET, BY METHOD, 2021-2028 (USD MILLION)
    • TABLE 241 US: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 242 US: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 243 US: TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 244 US: TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 245 US: TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 246 US: TRANSFECTION TECHNOLOGIES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.2.3 CANADA
      • 10.2.3.1 Rising investments in R&D to drive market
    • TABLE 247 CANADA: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 248 CANADA: TRANSFECTION TECHNOLOGIES MARKET, BY METHOD, 2021-2028 (USD MILLION)
    • TABLE 249 CANADA: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 250 CANADA: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 251 CANADA: TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 252 CANADA: TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 253 CANADA: TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 254 CANADA: TRANSFECTION TECHNOLOGIES MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 10.3 EUROPE
    • TABLE 255 EUROPE: INDICATIVE LIST OF THERAPIES APPROVED IN 2022
    • TABLE 256 EUROPE: INDICATIVE LIST OF PRODUCTS ANTICIPATED TO BE APPROVED IN 2023
    • 10.3.1 EUROPE: RECESSION IMPACT
    • TABLE 257 EUROPE: TRANSFECTION TECHNOLOGIES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 258 EUROPE: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 259 EUROPE: TRANSFECTION TECHNOLOGIES MARKET, BY METHOD, 2021-2028 (USD MILLION)
    • TABLE 260 EUROPE: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 261 EUROPE: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 262 EUROPE: TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 263 EUROPE: TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 264 EUROPE: TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 265 EUROPE: TRANSFECTION TECHNOLOGIES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.2 GERMANY
      • 10.3.2.1 Germany to hold largest share of European market till 2028
    • TABLE 266 GERMANY: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 267 GERMANY: TRANSFECTION TECHNOLOGIES MARKET, BY METHOD, 2021-2028 (USD MILLION)
    • TABLE 268 GERMANY: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 269 GERMANY: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 270 GERMANY: TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 271 GERMANY: TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 272 GERMANY: TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 273 GERMANY: TRANSFECTION TECHNOLOGIES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.3 UK
      • 10.3.3.1 Increasing government funding for genomic projects to drive market
    • TABLE 274 UK: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 275 UK: TRANSFECTION TECHNOLOGIES MARKET, BY METHOD, 2021-2028 (USD MILLION)
    • TABLE 276 UK: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 277 UK: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 278 UK: TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 279 UK: TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 280 UK: TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 281 UK: TRANSFECTION TECHNOLOGIES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.4 FRANCE
      • 10.3.4.1 Focus on collaborative development of advanced cell and gene therapies to promote market growth
    • TABLE 282 FRANCE: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 283 FRANCE: TRANSFECTION TECHNOLOGIES MARKET, BY METHOD, 2021-2028 (USD MILLION)
    • TABLE 284 FRANCE: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 285 FRANCE: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 286 FRANCE: TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 287 FRANCE: TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 288 FRANCE: TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 289 FRANCE: TRANSFECTION TECHNOLOGIES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.5 ITALY
      • 10.3.5.1 Rising R&D investments and growing biotech industry to drive market
    • TABLE 290 ITALY: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 291 ITALY: TRANSFECTION TECHNOLOGIES MARKET, BY METHOD, 2021-2028 (USD MILLION)
    • TABLE 292 ITALY: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 293 ITALY: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 294 ITALY: TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 295 ITALY: TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 296 ITALY: TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 297 ITALY: TRANSFECTION TECHNOLOGIES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.6 SPAIN
      • 10.3.6.1 Growing expansion of research centers to stimulate market growth
    • TABLE 298 SPAIN: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 299 SPAIN: TRANSFECTION TECHNOLOGIES MARKET, BY METHOD, 2021-2028 (USD MILLION)
    • TABLE 300 SPAIN: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 301 SPAIN: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 302 SPAIN: TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 303 SPAIN: TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 304 SPAIN: TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 305 SPAIN: TRANSFECTION TECHNOLOGIES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.7 REST OF EUROPE
    • TABLE 306 REST OF EUROPE: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 307 REST OF EUROPE: TRANSFECTION TECHNOLOGIES MARKET, BY METHOD, 2021-2028 (USD MILLION)
    • TABLE 308 REST OF EUROPE: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 309 REST OF EUROPE: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 310 REST OF EUROPE: TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 311 REST OF EUROPE: TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 312 REST OF EUROPE: TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 313 REST OF EUROPE: TRANSFECTION TECHNOLOGIES MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 10.4 ASIA PACIFIC
    • 10.4.1 ASIA PACIFIC: RECESSION IMPACT
    • FIGURE 31 ASIA PACIFIC: TRANSFECTION TECHNOLOGIES MARKET SNAPSHOT
    • TABLE 314 ASIA PACIFIC: TRANSFECTION TECHNOLOGIES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 315 ASIA PACIFIC: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 316 ASIA PACIFIC: TRANSFECTION TECHNOLOGIES MARKET, BY METHOD, 2021-2028 (USD MILLION)
    • TABLE 317 ASIA PACIFIC: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 318 ASIA PACIFIC: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 319 ASIA PACIFIC: TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 320 ASIA PACIFIC: TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 321 ASIA PACIFIC: TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 322 ASIA PACIFIC: TRANSFECTION TECHNOLOGIES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.4.2 CHINA
      • 10.4.2.1 Increasing R&D expenditure to propel market growth
    • TABLE 323 CHINA: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 324 CHINA: TRANSFECTION TECHNOLOGIES MARKET, BY METHOD, 2021-2028 (USD MILLION)
    • TABLE 325 CHINA: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 326 CHINA: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 327 CHINA: TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 328 CHINA: TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 329 CHINA: TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 330 CHINA: TRANSFECTION TECHNOLOGIES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.4.3 JAPAN
      • 10.4.3.1 Booming CGT & RM sector to drive market
    • TABLE 331 JAPAN: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 332 JAPAN: TRANSFECTION TECHNOLOGIES MARKET, BY METHOD, 2021-2028 (USD MILLION)
    • TABLE 333 JAPAN: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 334 JAPAN: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 335 JAPAN: TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 336 JAPAN: TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 337 JAPAN: TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 338 JAPAN: TRANSFECTION TECHNOLOGIES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.4.4 SOUTH KOREA
      • 10.4.4.1 Alliances and investments in research to drive market
    • TABLE 339 SOUTH KOREA: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 340 SOUTH KOREA: TRANSFECTION TECHNOLOGIES MARKET, BY METHOD, 2021-2028 (USD MILLION)
    • TABLE 341 SOUTH KOREA: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 342 SOUTH KOREA: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 343 SOUTH KOREA: TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 344 SOUTH KOREA: TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 345 SOUTH KOREA: TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 346 SOUTH KOREA: TRANSFECTION TECHNOLOGIES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.4.5 INDIA
      • 10.4.5.1 Growing demand for advanced treatment solutions to propel market growth
    • TABLE 347 INDIA: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 348 INDIA: TRANSFECTION TECHNOLOGIES MARKET, BY METHOD, 2021-2028 (USD MILLION)
    • TABLE 349 INDIA: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 350 INDIA: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 351 INDIA: TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 352 INDIA: TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 353 INDIA: TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 354 INDIA: TRANSFECTION TECHNOLOGIES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.4.6 AUSTRALIA
      • 10.4.6.1 Rising prevalence of chronic diseases and growing life science sector to drive market
    • TABLE 355 AUSTRALIA: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 356 AUSTRALIA: TRANSFECTION TECHNOLOGIES MARKET, BY METHOD, 2021-2028 (USD MILLION)
    • TABLE 357 AUSTRALIA: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 358 AUSTRALIA: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 359 AUSTRALIA: TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 360 AUSTRALIA: TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 361 AUSTRALIA: TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 362 AUSTRALIA: TRANSFECTION TECHNOLOGIES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.4.7 REST OF ASIA PACIFIC
    • TABLE 363 REST OF ASIA PACIFIC: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 364 REST OF ASIA PACIFIC: TRANSFECTION TECHNOLOGIES MARKET, BY METHOD, 2021-2028 (USD MILLION)
    • TABLE 365 REST OF ASIA PACIFIC: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 366 REST OF ASIA PACIFIC: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 367 REST OF ASIA PACIFIC: TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 368 REST OF ASIA PACIFIC: TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 369 REST OF ASIA PACIFIC: TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 370 REST OF ASIA PACIFIC: TRANSFECTION TECHNOLOGIES MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 10.5 LATIN AMERICA
    • 10.5.1 LATIN AMERICA: RECESSION IMPACT
    • TABLE 371 LATIN AMERICA: TRANSFECTION TECHNOLOGIES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 372 LATIN AMERICA: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 373 LATIN AMERICA: TRANSFECTION TECHNOLOGIES MARKET, BY METHOD, 2021-2028 (USD MILLION)
    • TABLE 374 LATIN AMERICA: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 375 LATIN AMERICA: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 376 LATIN AMERICA: TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 377 LATIN AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 378 LATIN AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 379 LATIN AMERICA: TRANSFECTION TECHNOLOGIES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.5.2 BRAZIL
      • 10.5.2.1 Brazil to hold largest share of LATAM market
    • TABLE 380 BRAZIL: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 381 BRAZIL: TRANSFECTION TECHNOLOGIES MARKET, BY METHOD, 2021-2028 (USD MILLION)
    • TABLE 382 BRAZIL: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 383 BRAZIL: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 384 BRAZIL: TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 385 BRAZIL: TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 386 BRAZIL: TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 387 BRAZIL: TRANSFECTION TECHNOLOGIES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.5.3 MEXICO
      • 10.5.3.1 Rising research activity to support market growth
    • TABLE 388 MEXICO: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 389 MEXICO: TRANSFECTION TECHNOLOGIES MARKET, BY METHOD, 2021-2028 (USD MILLION)
    • TABLE 390 MEXICO: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 391 MEXICO: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 392 MEXICO: TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 393 MEXICO: TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 394 MEXICO: TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 395 MEXICO: TRANSFECTION TECHNOLOGIES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.5.4 ARGENTINA
      • 10.5.4.1 Increasing government initiatives to drive market
    • TABLE 396 ARGENTINA: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 397 ARGENTINA: TRANSFECTION TECHNOLOGIES MARKET, BY METHOD, 2021-2028 (USD MILLION)
    • TABLE 398 ARGENTINA: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 399 ARGENTINA: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 400 ARGENTINA: TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 401 ARGENTINA: TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 402 ARGENTINA: TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 403 ARGENTINA: TRANSFECTION TECHNOLOGIES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.5.5 REST OF LATIN AMERICA
    • TABLE 404 REST OF LATIN AMERICA: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 405 REST OF LATIN AMERICA: TRANSFECTION TECHNOLOGIES MARKET, BY METHOD, 2021-2028 (USD MILLION)
    • TABLE 406 REST OF LATIN AMERICA: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 407 REST OF LATIN AMERICA: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 408 REST OF LATIN AMERICA: TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 409 REST OF LATIN AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 410 REST OF LATIN AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 411 REST OF LATIN AMERICA: TRANSFECTION TECHNOLOGIES MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 10.6 MIDDLE EAST & AFRICA
    • 10.6.1 MIDDLE EAST & AFRICA: RECESSION IMPACT
    • TABLE 412 MIDDLE EAST & AFRICA: TRANSFECTION TECHNOLOGIES MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 413 MIDDLE EAST & AFRICA: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 414 MIDDLE EAST & AFRICA: TRANSFECTION TECHNOLOGIES MARKET, BY METHOD, 2021-2028 (USD MILLION)
    • TABLE 415 MIDDLE EAST & AFRICA: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 416 MIDDLE EAST & AFRICA: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 417 MIDDLE EAST & AFRICA: TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 418 MIDDLE EAST & AFRICA: TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 419 MIDDLE EAST & AFRICA: TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 420 MIDDLE EAST & AFRICA: TRANSFECTION TECHNOLOGIES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.6.2 MIDDLE EAST
    • TABLE 421 MIDDLE EAST: TRANSFECTION TECHNOLOGIES MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 422 MIDDLE EAST: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 423 MIDDLE EAST: TRANSFECTION TECHNOLOGIES MARKET, BY METHOD, 2021-2028 (USD MILLION)
    • TABLE 424 MIDDLE EAST: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 425 MIDDLE EAST: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 426 MIDDLE EAST: TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 427 MIDDLE EAST: TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 428 MIDDLE EAST: TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 429 MIDDLE EAST: TRANSFECTION TECHNOLOGIES MARKET, BY END USER, 2021-2028 (USD MILLION)
      • 10.6.2.1 GCC Countries
        • 10.6.2.1.1 Increasing collaborations and partnerships to advance cell therapy to drive market
    • TABLE 430 GCC COUNTRIES: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 431 GCC COUNTRIES: TRANSFECTION TECHNOLOGIES MARKET, BY METHOD, 2021-2028 (USD MILLION)
    • TABLE 432 GCC COUNTRIES: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 433 GCC COUNTRIES: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 434 GCC COUNTRIES: TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 435 GCC COUNTRIES: TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 436 GCC COUNTRIES: TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 437 GCC COUNTRIES: TRANSFECTION TECHNOLOGIES MARKET, BY END USER, 2021-2028 (USD MILLION)
      • 10.6.2.2 Rest of the Middle East
    • TABLE 438 REST OF MIDDLE EAST: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 439 REST OF MIDDLE EAST: TRANSFECTION TECHNOLOGIES MARKET, BY METHOD, 2021-2028 (USD MILLION)
    • TABLE 440 REST OF MIDDLE EAST: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 441 REST OF MIDDLE EAST: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 442 REST OF MIDDLE EAST: TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 443 REST OF MIDDLE EAST: TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 444 REST OF MIDDLE EAST: TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 445 REST OF MIDDLE EAST: TRANSFECTION TECHNOLOGIES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.6.3 AFRICA
      • 10.6.3.1 Rising prevalence of HIV and cancer and growing precision medicine initiatives to fuel market growth
    • TABLE 446 AFRICA: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 447 AFRICA: TRANSFECTION TECHNOLOGIES MARKET, BY METHOD, 2021-2028 (USD MILLION)
    • TABLE 448 AFRICA: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 449 AFRICA: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 450 AFRICA: TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 451 AFRICA: TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 452 AFRICA: TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 453 AFRICA: TRANSFECTION TECHNOLOGIES MARKET, BY END USER, 2021-2028 (USD MILLION)

11 COMPETITIVE LANDSCAPE

  • 11.1 OVERVIEW
  • 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
  • 11.3 REVENUE SHARE ANALYSIS
  • 11.4 MARKET SHARE ANALYSIS
    • FIGURE 34 TRANSFECTION TECHNOLOGIES MARKET SHARE ANALYSIS, BY KEY PLAYER, 2022
    • TABLE 454 TRANSFECTION TECHNOLOGIES MARKET: DEGREE OF COMPETITION
  • 11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS
    • 11.5.1 STARS
    • 11.5.2 EMERGING LEADERS
    • 11.5.3 PERVASIVE PLAYERS
    • 11.5.4 PARTICIPANTS
    • 11.5.5 COMPANY FOOTPRINT
    • TABLE 455 COMPANY FOOTPRINT
    • TABLE 456 COMPANY PRODUCT FOOTPRINT
    • TABLE 457 COMPANY REGION FOOTPRINT
  • 11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES
    • 11.6.1 PROGRESSIVE COMPANIES
    • 11.6.2 RESPONSIVE COMPANIES
    • 11.6.3 DYNAMIC COMPANIES
    • 11.6.4 STARTING BLOCKS
    • FIGURE 36 TRANSFECTION TECHNOLOGIES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES) (2022)
    • 11.6.5 COMPETITIVE BENCHMARKING
    • TABLE 458 TRANSFECTION TECHNOLOGIES MARKET: KEY STARTUPS/SMES
    • TABLE 459 TRANSFECTION TECHNOLOGIES MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
  • 11.7 COMPETITIVE SCENARIO
    • 11.7.1 PRODUCT LAUNCHES
    • TABLE 460 TRANSFECTION TECHNOLOGIES MARKET: KEY PRODUCT LAUNCHES, JANUARY 2020-DECEMBER 2023
    • 11.7.2 DEALS
    • TABLE 461 TRANSFECTION TECHNOLOGIES MARKET: KEY DEALS, JANUARY 2020- DECEMBER 2023
    • 11.7.3 OTHER DEVELOPMENTS
    • TABLE 462 TRANSFECTION TECHNOLOGIES MARKET: OTHER DEVELOPMENTS, JANUARY 2020-NOVEMBER 2023

12 COMPANY PROFILES

  • 12.1 KEY PLAYERS
  • (Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))**
    • 12.1.1 THERMO FISHER SCIENTIFIC INC.
    • TABLE 463 THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW
    • FIGURE 37 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2022)
    • TABLE 464 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED
    • TABLE 465 THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES
    • TABLE 466 THERMO FISHER SCIENTIFIC INC.: DEALS
    • TABLE 467 THERMO FISHER SCIENTIFIC INC.: OTHER DEVELOPMENTS
    • 12.1.2 BIO-RAD LABORATORIES, INC.
    • TABLE 468 BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW
    • FIGURE 38 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2022)
    • TABLE 469 BIO-RAD LABORATORIES, INC.: PRODUCTS OFFERED
    • 12.1.3 QIAGEN
    • TABLE 470 QIAGEN: BUSINESS OVERVIEW
    • FIGURE 39 QIAGEN: COMPANY SNAPSHOT (2022)
    • TABLE 471 QIAGEN: PRODUCTS OFFERED
    • 12.1.4 MERCK KGAA
    • TABLE 472 MERCK KGAA: BUSINESS OVERVIEW
    • FIGURE 40 MERCK KGAA: COMPANY SNAPSHOT (2022)
    • TABLE 473 MERCK KGAA: PRODUCTS OFFERED
    • TABLE 474 MERCK KGAA: DEALS
    • TABLE 475 MERCK KGAA: OTHER DEVELOPMENTS
    • 12.1.5 SARTORIUS AG (POLYPLUS)
    • TABLE 476 SARTORIUS AG (POLYPLUS): BUSINESS OVERVIEW
    • FIGURE 41 SARTORIUS AG (POLYPLUS): COMPANY SNAPSHOT (2022)
    • TABLE 477 SARTORIUS AG (POLYPLUS): PRODUCTS OFFERED
    • TABLE 478 SARTORIUS AG (POLYPLUS): PRODUCT LAUNCHES
    • TABLE 479 SARTORIUS AG (POLYPLUS): DEALS
    • 12.1.6 LONZA
    • TABLE 480 LONZA: BUSINESS OVERVIEW
    • FIGURE 42 LONZA: COMPANY SNAPSHOT (2022)
    • TABLE 481 LONZA: PRODUCTS OFFERED
    • TABLE 482 LONZA: PRODUCT LAUNCHES
    • TABLE 483 LONZA: DEALS
    • 12.1.7 F. HOFFMANN-LA ROCHE LTD.
    • TABLE 484 F. HOFFMANN-LA ROCHE LTD.: BUSINESS OVERVIEW
    • FIGURE 43 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2022)
    • TABLE 485 F. HOFFMAN-LA ROCHE LTD.: PRODUCTS OFFERED
    • 12.1.8 AGILENT TECHNOLOGIES, INC.
    • TABLE 486 AGILENT TECHNOLOGIES, INC.: BUSINESS OVERVIEW
    • FIGURE 44 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2022)
    • TABLE 487 AGILENT TECHNOLOGIES, INC.: PRODUCTS OFFERED
    • TABLE 488 AGILENT TECHNOLOGIES, INC.: DEALS
    • 12.1.9 MAXCYTE
    • TABLE 489 MAXCYTE: BUSINESS OVERVIEW
    • FIGURE 45 MAXCYTE: COMPANY SNAPSHOT (2022)
    • TABLE 490 MAXCYTE: PRODUCTS OFFERED
    • TABLE 491 MAXCYTE: PRODUCT LAUNCHES
    • TABLE 492 MAXCYTE: DEALS
    • 12.1.10 REVVITY
    • TABLE 493 REVVITY: BUSINESS OVERVIEW
    • FIGURE 46 REVVITY: COMPANY SNAPSHOT (2022)
    • TABLE 494 REVVITY: PRODUCTS OFFERED
    • TABLE 495 REVVITY: DEALS
    • TABLE 496 REVVITY: OTHER DEVELOPMENTS
    • 12.1.11 TAKARA BIO INC.
    • TABLE 497 TAKARA BIO INC.: BUSINESS OVERVIEW
    • FIGURE 47 TAKARA BIO INC.: COMPANY SNAPSHOT (2022)
    • TABLE 498 TAKARA BIO INC.: COMPANY OVERVIEW
    • 12.1.12 PROMEGA CORPORATION
    • TABLE 499 PROMEGA CORPORATION: BUSINESS OVERVIEW
    • TABLE 500 PROMEGA CORPORATION: PRODUCTS OFFERED
    • 12.1.13 DANAHER CORPORATION
    • TABLE 501 DANAHER CORPORATION: BUSINESS OVERVIEW
    • FIGURE 48 DANAHER CORPORATION: COMPANY SNAPSHOT (2022)
    • TABLE 502 DANAHER CORPORATION: PRODUCTS OFFERED
    • TABLE 503 DANAHER CORPORATION: PRODUCT LAUNCHES
    • TABLE 504 DANAHER CORPORATION: DEALS
    • TABLE 505 DANAHER CORPORATION: OTHER DEVELOPMENTS
  • 12.2 OTHER PLAYERS
    • 12.2.1 BOC SCIENCES
    • TABLE 506 BOC SCIENCES: COMPANY OVERVIEW
    • 12.2.2 RJH BIOSCIENCES
    • TABLE 507 RJH BIOSCIENCES: COMPANY OVERVIEW
    • 12.2.3 SYNVOLUX
    • TABLE 508 SYNVOLUX: COMPANY OVERVIEW
    • 12.2.4 ALTOGEN BIOSYSTEMS
    • TABLE 509 ALTOGEN BIOSYSTEMS: COMPANY OVERVIEW
    • 12.2.5 BIOIVT
    • TABLE 510 BIOIVT: COMPANY OVERVIEW
    • 12.2.6 INCELLA GMBH
    • TABLE 511 INCELLA GMBH (SCREENFECT): COMPANY OVERVIEW
    • 12.2.7 INVIVOGEN
    • TABLE 512 INVIVOGEN: COMPANY OVERVIEW
    • 12.2.8 PHOREUS BIOTECH
    • TABLE 513 PHOREUS BIOTECH: COMPANY OVERVIEW
    • 12.2.9 STEMCELL TECHNOLOGIES
    • TABLE 514 STEMCELL TECHNOLOGIES: COMPANY OVERVIEW
    • 12.2.10 EZ BIOSYSTEMS
    • TABLE 515 EZ BIOSYSTEMS: COMPANY OVERVIEW
    • 12.2.11 OZ BIOSCIENCES
    • TABLE 516 OZ BIOSCIENCES: COMPANY OVERVIEW
    • 12.2.12 CHEMICELL GMBH
    • TABLE 517 CHEMICELL GMBH: COMPANY OVERVIEW
  • *Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

13 APPENDIX

  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3 CUSTOMIZATION OPTIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS